Article Versions Notes

Yagolovich AV, Isakova AA, Artykov AA, Vorontsova YV, Mazur DV, Antipova NV, Pavlyukov MS, Shakhparonov MI, Gileva AM, Markvicheva EA, et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. International Journal of Molecular Sciences. 2022; 23(20):12687. https://doi.org/10.3390/ijms232012687

Yagolovich, Anne V., Alina A. Isakova, Artem A. Artykov, Yekaterina V. Vorontsova, Diana V. Mazur, Nadezhda V. Antipova, Marat S. Pavlyukov, Mikhail I. Shakhparonov, Anastasia M. Gileva, Elena A. Markvicheva, and et al. 2022. "DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma" International Journal of Molecular Sciences 23, no. 20: 12687. https://doi.org/10.3390/ijms232012687

Yagolovich, A. V., Isakova, A. A., Artykov, A. A., Vorontsova, Y. V., Mazur, D. V., Antipova, N. V., Pavlyukov, M. S., Shakhparonov, M. I., Gileva, A. M., Markvicheva, E. A., Plotnikova, E. A., Pankratov, A. A., Kirpichnikov, M. P., Gasparian, M. E., & Dolgikh, D. A. (2022). DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. International Journal of Molecular Sciences, 23(20), 12687. https://doi.org/10.3390/ijms232012687